Other
Drug Facts
Distributed by Obagi Cosmeceuticals LLC, Long Beach, CA 90806
The following Structured Product Label (SPL) was submitted to the FDA by Obagi Cosmeceuticals Llc for the product Obagi Nu-derm System Normal-dry Skin Transformation Trial (NDC 62032-913). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - purpose, uses, warnings, otc - do not use, otc - stop use, otc - when using, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Distributed by Obagi Cosmeceuticals LLC, Long Beach, CA 90806
| Active ingredients | Purpose |
|---|---|
| Homosalate 10% | Sunscreen |
| Octisalate 5% | Sunscreen |
| Zinc Oxide 16.5% | Sunscreen |
For external use only
Do not use on damaged or broken skin
Stop use and ask a doctor if rash occurs
When using this product keep out of eyes. Rinse with water to remove.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Water (Aqua), C15-19 Alkane, Octyldodecyl Neopentanoate, Polymethylsilsesquioxane, Sorbitan Olivate, Silica, Polyglyceryl-6 Polyricinoleate, Sodium Chloride, Xanthan Gum, Glycerin, Hydroxyacetophenone, Disodium EDTA, 1,2-Hexanediol, Caprylyl Glycol, Sodium Hydroxide, Triethoxycaprylylsilane, Polyhydroxystearic Acid, Disteardimonium Hectorite, Polyglyceryl-2 Isostearate, Euphorbia Cerifera (Candelilla) Wax, Beeswax (Cera Alba), Dimethicone
1.800.636.7546 Monday–Friday 9 a.m.–4 p.m. PST
* Please review the disclaimer below.